(b)(4).There was no reported device malfunction, and the product was not returned.The reported patient effects of headache, neurological deficit/dysfunction, pain, and restenosis are listed in the instructions for use (ifu) as potential adverse events.Although a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined, there is no indication of a product quality deficiency with respect to manufacturing, design or labeling.
|
It was reported that on (b)(6) 2012, the patient underwent a stenting procedure with placement of a 7-10 x 40 mm acculink stent in the heavily calcified right internal/common carotid artery.On (b)(6) 2013, the patient presented to the emergency room after experiencing right-sided neck pain which radiated to a severe right periorbital headache/migraine headache, confusion and some memory loss.Diagnosis of encephalopathy and transient ischemic attack were made.Computerized axial tomography, magnetic resonance imaging, magnetic resonance angiography and carotid ultrasound were performed and noted in-stent restenosis.The patient was rehospitalized.Lisinopril was given and plavix was re-started.The patient's metoprolol dosage was decreased.There was no additional intervention performed, although smoking cessation was discussed.The patient will continue to be treated with medications at this time.No additional information was provided.
|